Echinococcus granulosus indirect ELISA controls

Timely and accurate diagnosis is critical for effective treatment. ELISA is one of the common diagnostic methods for detecting specific antibodies to Echinococcus granulosus. In this analysis, serum from patients with echinococcosis is often used as a positive control. However human serum with a high level of antibodies to echinococcus is a very rare material. There are very few patients with this invasion, and it is almost impossible to obtain plasma to create a positive control. Also, any human serum or blood plasma is a potential source of infection.
To solve these problems, we propose synthetic positive controls based on monoclonal antibodies.These controls not only eliminate the risk of contamination, but also offer a number of benefits, including increased stability, reduced lot-to-lot variation, affordability and ease of standardization. Our set of synthetic controls for indirect ELISA has proven its reliability over the years in the production of diagnostic kits.
To ensure the stability of the control material, we offer specially developed stabilizers.